US Stock MarketDetailed Quotes

SNOA Sonoma Pharmaceuticals

Watchlist

0.2479
-0.0608-19.70%

Close Aug 9 16:00 ET

0.2450
-0.0029-1.17%

Post 19:59 ET

4.75MMarket Cap-799P/E (TTM)

Sonoma Pharmaceuticals Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Quarterly+Annual

YOY

Hide blank lines

(Q1)Jun 30, 2024

(FY)Mar 31, 2024

(Q4)Mar 31, 2024

(Q3)Dec 31, 2023

(Q2)Sep 30, 2023

(Q1)Jun 30, 2023

(FY)Mar 31, 2023

(Q4)Mar 31, 2023

(Q3)Dec 31, 2022

(Q2)Sep 30, 2022

Total revenue

-1.05%3.39M

-4.05%12.74M

14.10%3.44M

6.59%3.14M

-18.01%2.73M

-13.96%3.43M

5.10%13.27M

31.16%3.01M

1.45%2.94M

-11.03%3.33M

Operating revenue

-1.05%3.39M

-4.05%12.74M

14.10%3.44M

6.59%3.14M

-18.01%2.73M

-13.96%3.43M

5.10%13.27M

31.16%3.01M

1.45%2.94M

-11.03%3.33M

Cost of revenue

-6.21%2.09M

-9.15%7.99M

9.21%2.35M

-20.59%1.68M

-3.01%1.74M

-4.88%2.22M

1.85%8.8M

-2.36%2.15M

24.37%2.11M

-28.29%1.8M

Gross profit

8.47%1.31M

5.99%4.75M

26.27%1.09M

75.69%1.46M

-35.55%990K

-26.85%1.2M

12.12%4.48M

800.00%864K

-30.92%831K

23.77%1.54M

Operating expense

1.43%2.48M

4.41%9.45M

24.32%2.5M

-13.55%2.3M

-3.04%2.2M

-2.28%2.44M

-8.43%9.05M

-36.28%2.01M

23.32%2.67M

2.81%2.27M

Selling and administrative expenses

-5.19%2.01M

-14.31%7.58M

15.52%2.09M

-36.10%1.7M

-19.59%1.66M

-7.67%2.12M

-9.38%8.84M

-42.58%1.81M

24.82%2.67M

-5.83%2.07M

Research and development costs

44.62%470K

803.86%1.87M

103.48%409K

--601K

168.00%536K

57.77%325K

65.60%207K

4,925.00%201K

--0

1,900.00%200K

Operating profit

5.40%-1.17M

-2.87%-4.7M

-22.84%-1.41M

53.98%-844K

-65.25%-1.21M

-45.03%-1.24M

22.37%-4.57M

62.52%-1.15M

-91.44%-1.83M

24.17%-731K

Net non-operating interest income expense

Other net income (expense)

183.41%176K

46.25%-330K

117.12%50K

-11.27%-79K

51.61%-90K

-214.93%-211K

-228.18%-614K

-37.09%-292K

-745.45%-71K

-121.31%-186K

Other non- operating income (expenses)

183.41%176K

46.25%-330K

117.12%50K

-11.27%-79K

51.61%-90K

-214.93%-211K

-55.84%-614K

68.80%-292K

-745.45%-71K

-125.73%-186K

Income before tax

31.29%-997K

2.95%-5.03M

5.56%-1.36M

51.55%-923K

-41.55%-1.3M

-57.38%-1.45M

4.32%-5.18M

56.15%-1.44M

-101.80%-1.91M

-865.26%-917K

Income tax

542.42%146K

-493.94%-196K

-122.90%-292K

-267.65%-57K

86.00%186K

5.71%-33K

90.06%-33K

61.24%-131K

34K

1,900.00%100K

Net income

19.39%-1.14M

6.13%-4.84M

18.43%-1.07M

55.34%-866K

-45.92%-1.48M

-59.86%-1.42M

-1.28%-5.15M

55.57%-1.31M

-105.40%-1.94M

-917.00%-1.02M

Net income continuous Operations

19.39%-1.14M

6.13%-4.84M

18.43%-1.07M

55.34%-866K

-45.92%-1.48M

-59.86%-1.42M

-1.28%-5.15M

55.57%-1.31M

-105.40%-1.94M

-917.00%-1.02M

Minority interest income

Net income attributable to the parent company

19.39%-1.14M

6.13%-4.84M

18.43%-1.07M

55.34%-866K

-45.92%-1.48M

-59.86%-1.42M

-1.28%-5.15M

55.57%-1.31M

-105.40%-1.94M

-917.00%-1.02M

Preferred stock dividends

Other preferred stock dividends

Net income attributable to common stockholders

19.39%-1.14M

6.13%-4.84M

18.43%-1.07M

55.34%-866K

-45.92%-1.48M

-59.86%-1.42M

-1.28%-5.15M

55.57%-1.31M

-105.40%-1.94M

-917.00%-1.02M

Basic earnings per share

75.86%-0.07

65.13%-0.53

75.58%-0.0684

87.10%-0.08

12.12%-0.29

0.00%-0.29

20.83%-1.52

73.83%-0.28

-100.00%-0.62

-725.00%-0.33

Diluted earnings per share

75.86%-0.07

65.13%-0.53

75.58%-0.0684

87.10%-0.08

12.12%-0.29

0.00%-0.29

20.83%-1.52

73.83%-0.28

-100.00%-0.62

-725.00%-0.33

Dividend per share

Currency Unit

USD

Accounting Standards

US-GAAP

Audit Opinions

Unqualified Opinion with Explanatory Notes

	(Q1)Jun 30, 2024	(FY)Mar 31, 2024	(Q4)Mar 31, 2024	(Q3)Dec 31, 2023	(Q2)Sep 30, 2023	(Q1)Jun 30, 2023	(FY)Mar 31, 2023	(Q4)Mar 31, 2023	(Q3)Dec 31, 2022	(Q2)Sep 30, 2022
Total revenue	-1.05%3.39M	-4.05%12.74M	14.10%3.44M	6.59%3.14M	-18.01%2.73M	-13.96%3.43M	5.10%13.27M	31.16%3.01M	1.45%2.94M	-11.03%3.33M
Operating revenue	-1.05%3.39M	-4.05%12.74M	14.10%3.44M	6.59%3.14M	-18.01%2.73M	-13.96%3.43M	5.10%13.27M	31.16%3.01M	1.45%2.94M	-11.03%3.33M
Cost of revenue	-6.21%2.09M	-9.15%7.99M	9.21%2.35M	-20.59%1.68M	-3.01%1.74M	-4.88%2.22M	1.85%8.8M	-2.36%2.15M	24.37%2.11M	-28.29%1.8M
Gross profit	8.47%1.31M	5.99%4.75M	26.27%1.09M	75.69%1.46M	-35.55%990K	-26.85%1.2M	12.12%4.48M	800.00%864K	-30.92%831K	23.77%1.54M
Operating expense	1.43%2.48M	4.41%9.45M	24.32%2.5M	-13.55%2.3M	-3.04%2.2M	-2.28%2.44M	-8.43%9.05M	-36.28%2.01M	23.32%2.67M	2.81%2.27M
Selling and administrative expenses	-5.19%2.01M	-14.31%7.58M	15.52%2.09M	-36.10%1.7M	-19.59%1.66M	-7.67%2.12M	-9.38%8.84M	-42.58%1.81M	24.82%2.67M	-5.83%2.07M
Research and development costs	44.62%470K	803.86%1.87M	103.48%409K	--601K	168.00%536K	57.77%325K	65.60%207K	4,925.00%201K	--0	1,900.00%200K
Operating profit	5.40%-1.17M	-2.87%-4.7M	-22.84%-1.41M	53.98%-844K	-65.25%-1.21M	-45.03%-1.24M	22.37%-4.57M	62.52%-1.15M	-91.44%-1.83M	24.17%-731K
Net non-operating interest income expense
Other net income (expense)	183.41%176K	46.25%-330K	117.12%50K	-11.27%-79K	51.61%-90K	-214.93%-211K	-228.18%-614K	-37.09%-292K	-745.45%-71K	-121.31%-186K
Other non- operating income (expenses)	183.41%176K	46.25%-330K	117.12%50K	-11.27%-79K	51.61%-90K	-214.93%-211K	-55.84%-614K	68.80%-292K	-745.45%-71K	-125.73%-186K
Income before tax	31.29%-997K	2.95%-5.03M	5.56%-1.36M	51.55%-923K	-41.55%-1.3M	-57.38%-1.45M	4.32%-5.18M	56.15%-1.44M	-101.80%-1.91M	-865.26%-917K
Income tax	542.42%146K	-493.94%-196K	-122.90%-292K	-267.65%-57K	86.00%186K	5.71%-33K	90.06%-33K	61.24%-131K	34K	1,900.00%100K
Net income	19.39%-1.14M	6.13%-4.84M	18.43%-1.07M	55.34%-866K	-45.92%-1.48M	-59.86%-1.42M	-1.28%-5.15M	55.57%-1.31M	-105.40%-1.94M	-917.00%-1.02M
Net income continuous Operations	19.39%-1.14M	6.13%-4.84M	18.43%-1.07M	55.34%-866K	-45.92%-1.48M	-59.86%-1.42M	-1.28%-5.15M	55.57%-1.31M	-105.40%-1.94M	-917.00%-1.02M
Minority interest income
Net income attributable to the parent company	19.39%-1.14M	6.13%-4.84M	18.43%-1.07M	55.34%-866K	-45.92%-1.48M	-59.86%-1.42M	-1.28%-5.15M	55.57%-1.31M	-105.40%-1.94M	-917.00%-1.02M
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders	19.39%-1.14M	6.13%-4.84M	18.43%-1.07M	55.34%-866K	-45.92%-1.48M	-59.86%-1.42M	-1.28%-5.15M	55.57%-1.31M	-105.40%-1.94M	-917.00%-1.02M
Basic earnings per share	75.86%-0.07	65.13%-0.53	75.58%-0.0684	87.10%-0.08	12.12%-0.29	0.00%-0.29	20.83%-1.52	73.83%-0.28	-100.00%-0.62	-725.00%-0.33
Diluted earnings per share	75.86%-0.07	65.13%-0.53	75.58%-0.0684	87.10%-0.08	12.12%-0.29	0.00%-0.29	20.83%-1.52	73.83%-0.28	-100.00%-0.62	-725.00%-0.33
Dividend per share
Currency Unit	USD	USD	USD	USD	USD	USD	USD	USD	USD	USD
Accounting Standards	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP
Audit Opinions	--	Unqualified Opinion with Explanatory Notes	--	--	--	--	Unqualified Opinion with Explanatory Notes	--	--	--

Analysis

Analyst Rating

No Data

Price Target

No Data

Overall